Cargando…
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
BACKGROUND: In this study, we tried to access the efficacy and safety of oxaliplatin plus S-1 with intraperitoneal paclitaxel (PTX) for the treatment of Chinese advanced gastric cancer with peritoneal metastases. PATIENTS AND METHODS: Thirty patients diagnosed with advanced gastric cancer underwent...
Autores principales: | Shi, Min, Yang, Zhongyin, Lu, Sheng, Liu, Wentao, Ni, Zhentian, Yao, Xuexin, Hua, Zichen, Feng, Runhua, Zheng, Yanan, Wang, Zhenqiang, Sah, Birendra Kumar, Chen, Mingmin, Zhu, Zhenglun, He, Changyu, Li, Chen, Zhang, Jun, Yan, Chao, Yan, Min, Zhu, Zhenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684127/ https://www.ncbi.nlm.nih.gov/pubmed/34922478 http://dx.doi.org/10.1186/s12885-021-09027-5 |
Ejemplares similares
-
Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
por: Xu, Wei, et al.
Publicado: (2021) -
Neoadjuvant Chemotherapy Versus Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
por: Xu, Wei, et al.
Publicado: (2021) -
Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020) -
Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
por: Xu, Wei, et al.
Publicado: (2021) -
Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer Cells
por: Yang, Zhongyin, et al.
Publicado: (2021)